Successes and lessons learned in database development for national multi-site cancer care delivery research trials: the Alliance for Clinical Trials in Oncology experience

Authors: David Zahrieh, Shauna L. Hillman, Angelina D. Tan, Jennifer L. Frank, Travis Dockter, Bobbi Jo Meyers, Cassie L. Cherevko, Elizabeth S. Peil, Shaylene McCue, Oudom Kour, Heather J. Gunn, Heather B. Neuman, George J. Chang, Electra D. Paskett, Sumithra J. Mandrekar, Amylou C. Dueck

Source: Trials, Vol 23, Iss 1, Pp 1-13 (2022)

Subject Terms: Cancer care delivery research, Clinical trial management and optimization, Clinical trial operations, Data management and monitoring, Medicine (General), R5-920

File Description: electronic resource

Relation: https://doaj.org/toc/1745-6215

Access URL: https://doaj.org/article/4735ccaab1ad467b99542789d0367e53

Succinct Cancer Clinical Trial Consent Forms in Rural Patients With Cancer: A Secondary Analysis of a Randomized, Double-Blinded study

Authors: Jana Wieland MD, Daniel Satele BS, Yahya Almodallal MBBS, Paul Novotny MS, Stephanie L. Pritzl MD, Sumithra J. Mandrekar PhD, Aminah Jatoi MD

Source: Journal of Patient Experience, Vol 9 (2022)

Subject Terms: Medicine (General), R5-920

File Description: electronic resource

Relation: https://doaj.org/toc/2374-3743

Access URL: https://doaj.org/article/ff33b49e34fa44ad86de9f7d86d6f11a

Physician-Reported Experience and Understanding of Adverse Event Attribution in Cancer Clinical Trials

Authors: Jennifer G. Le-Rademacher, PhD, Elizabeth M. Storrick, BA, Aminah Jatoi, MD, Sumithra J. Mandrekar, PhD

Source: Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 3, Iss 2, Pp 176-182 (2019)

Subject Terms: Medicine (General), R5-920

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2542454819300074; https://doaj.org/toc/2542-4548

Access URL: https://doaj.org/article/ba08914ecf734c9ab22521d113e17415

Modeling tumor measurement data to predict overall survival (OS) in cancer clinical trials

Authors: Fang-Shu Ou, Jun Tang, Ming-Wen An, Sumithra J. Mandrekar

Source: Contemporary Clinical Trials Communications, Vol 23, Iss , Pp 100827- (2021)

Subject Terms: Tumor measurement data, RECIST, Prediction, Cancer trial, Medicine (General), R5-920

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2451865421001289; https://doaj.org/toc/2451-8654

Access URL: https://doaj.org/article/d6d34e1f83754cbd87cc35a612e183ca

Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance)

Authors: John C. Byrd, Amy S. Ruppert, Nyla A. Heerema, Alese E. Halvorson, Eva Hoke, Mitchell R. Smith, John E. Godwin, Stephen Couban, Todd A. Fehniger, Michael J. Thirman, Martin S. Tallman, Frederick R. Appelbaum, Richard M. Stone, Sue Robinson, Julie E. Chang, Sumithra J. Mandrekar, Richard A. Larson

Source: Blood Advances, Vol 2, Iss 14, Pp 1705-1718 (2018)

Subject Terms: Specialties of internal medicine, RC581-951

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2473952920309265; https://doaj.org/toc/2473-9529

Access URL: https://doaj.org/article/6202bf27c493461da18051facf6da22d

Missing tumor measurement (TM) data in the search for alternative TM-based endpoints in cancer clinical trials

Authors: Ming-Wen An, Jun Tang, Axel Grothey, Daniel J. Sargent, Fang-Shu Ou, Sumithra J. Mandrekar

Source: Contemporary Clinical Trials Communications, Vol 17, Iss , Pp - (2020)

Subject Terms: Medicine (General), R5-920

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2451865419302546; https://doaj.org/toc/2451-8654

Access URL: https://doaj.org/article/975608b1cfed44849fd35ce68d122996

A phase 2 study incorporating sorafenib into the chemotherapy for older adults with FLT3-mutated acute myeloid leukemia: CALGB 11001

Authors: Geoffrey L. Uy, Sumithra J. Mandrekar, Kristina Laumann, Guido Marcucci, Weiqiang Zhao, Mark J. Levis, Heidi D. Klepin, Maria R. Baer, Bayard L. Powell, Peter Westervelt, Daniel J. DeAngelo, Wendy Stock, Ben Sanford, William G. Blum, Clara D. Bloomfield, Richard M. Stone, Richard A. Larson

Source: Blood Advances, Vol 1, Iss 5, Pp 331-340 (2017)

Subject Terms: Specialties of internal medicine, RC581-951

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2473952920304158; https://doaj.org/toc/2473-9529

Access URL: https://doaj.org/article/1ff307f46bdf469891e82aad13860cff

This result is not displayed to guests.
Login for full access.

The value of combined‐modality therapy in elderly patients with stage III nonsmall cell lung cancer.

Authors: Steven E. Schild¹, Sumithra J. Mandrekar², Aminah Jatoi³, William L. McGinnis⁴, Phillip J. Stella⁵, Richard L. Deming¹, James R. Jett⁶, Yolanda I. Garces¹, Katie L. Allen², Alex A. Adjei³

Source: Cancer (0008543X). Jul2007, Vol. 110 Issue 2, p363-368. 6p.

Subject Terms: *LUNG cancer, *CANCER cells, *DRUG therapy, *MEDICAL radiology, *CLINICAL trials

A pooled analysis of quality of life measures and adverse events data in north central cancer treatment group lung cancer clinical trials.

Authors: Mashele M. Huschka¹, Sumithra J. Mandrekar¹, Paul L. Schaefer², James R. Jett³, Jeff A. Sloan¹

Source: Cancer (0008543X). Feb2007, Vol. 109 Issue 4, p787-795. 9p.

Subject Terms: *QUALITY of life, *CANCER patients, *LUNG cancer, *CANCER treatment, *CLINICAL trials